Inflation Reduction Act – Implications on the biopharmaceutical industry

Tuesday, January 10, 2023  |  7:30 am

Panelists

Kirsten Axelsen, Policy Advisor at Charles River Associates
Jim Greenwood, Chair, Life Sciences Policy Practice at DLA Piper
Rhett Johnson, Vice President, Life Sciences at Charles River Associates
Darius Lakdawalla, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation at University of Southern California
John Stanford, Executive Director at Incubate

Moderator

Greg Bell, Vice President and Practice Leader, Life Sciences at Charles River Associates

If you are interested in registering for this event, please email us at eventsteam@crai.com to be added to the waitlist.